Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women-Reference-Cited by-同舟云学术

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Published:2010-03-03 Issue:5 Volume:102 Page:325-339
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Muñoz Nubia,Kjaer Susanne K.,Sigurdsson Kristján,Iversen Ole-Erik,Hernandez-Avila Mauricio,Wheeler Cosette M.,Perez Gonzalo,Brown Darron R.,Koutsky Laura A.,Tay Eng Hseon,Garcia Patricía J.,Ault Kevin A.,Garland Suzanne M.,Leodolter Sepp,Olsson Sven-Eric,Tang Grace W. K.,Ferris Daron G.,Paavonen Jorma,Steben Marc,Bosch F. Xavier,Dillner Joakim,Huh Warner K.,Joura Elmar A.,Kurman Robert J.,Majewski Slawomir,Myers Evan R.,Villa Luisa L.,Taddeo Frank J.,Roberts Christine,Tadesse Amha,Bryan Janine T.,Lupinacci Lisa C.,Giacoletti Katherine E. D.,Sings Heather L.,James Margaret K.,Hesley Teresa M.,Barr Eliav,Haupt Richard M.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/102/5/325/17310863/djp534.pdf

Reference42 articles.

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

2. Epidemiologic classification of human papillomavirus types associated with cervical cancer;Muñoz;N Engl J Med,2003

3. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial;Harper;Lancet,2006

4. Impact of vaccination with Cervarix™on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age;Harper;Gynecol Oncol,2008

Cited by 443 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of HPV-associated cancers: From epidemiology to prevention;Pathology - Research and Practice;2024-11

2. Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ—population-based follow-up of two cluster-randomized trials;Frontiers in Cellular and Infection Microbiology;2024-09-09

3. Unveiling a Dermatological Rarity: The Enigma of Vulvar Intraepithelial Neoplasia Grade III (HSIL) and the Role of p53 in Its Development;Biomedicines;2024-08-08

4. Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study;PLOS ONE;2024-06-25

5. Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses;Viruses;2024-03-08